RELIASENSE Trademark

Trademark Overview

On Monday, November 15, 2021, a trademark application was filed for RELIASENSE with the United States Patent and Trademark Office. The USPTO has given the RELIASENSE trademark a serial number of 97124577. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 14, 2024. This trademark is owned by LifeScan IP Holdings, LLC. The RELIASENSE trademark is filed in the Medical Instrument Products category with the following description:

Blood glucose meters and monitoring devices for medical purposes
reliasense

General Information

Serial Number97124577
Word MarkRELIASENSE
Filing DateMonday, November 15, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements

Goods and ServicesBlood glucose meters and monitoring devices for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, June 15, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLifeScan IP Holdings, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBeverly Hills, CA 90210
Party NameLifeScan IP Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBeverly Hills, CA 90210

Trademark Events

Event DateEvent Description
Tuesday, June 14, 2022ASSIGNED TO EXAMINER
Thursday, November 18, 2021NEW APPLICATION ENTERED
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 15, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, June 15, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 15, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 15, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Thursday, February 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 9, 2023SOU EXTENSION 1 FILED
Thursday, February 9, 2023SOU EXTENSION 1 GRANTED
Saturday, February 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2024SOU EXTENSION 3 GRANTED
Monday, October 14, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 14, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, March 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2023SOU EXTENSION 2 FILED
Monday, September 11, 2023SOU EXTENSION 2 GRANTED
Tuesday, March 12, 2024SOU EXTENSION 3 FILED
Tuesday, March 12, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

reliasense medical purposes devices monitoring glucose meters blood